Skip to main content
Press release February 24, 2026

Alector to Participate in the TD Cowen 46th Annual Health Care Conference

Alector, Inc. (ALEC)

SOUTH SAN FRANCISCO, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that management will participate in a corporate
View original release